Value of blood‐based biomarker testing to diagnose, identify and monitor patients with Alzheimer's Disease ‐ A structured literature review

Abstract

Background: Understanding the available evidence for the validity and utility of tests used to diagnose and monitor patients with early Alzheimer's Disease (AD) is essential for informed care decisions, including amyloid‐targeting monoclonal antibody therapy initiation.

The paper